Baidu
map

2019 AHA科学声明:急性肺栓塞介入治疗—当前状况和新证据发展

2019-11-04 美国心脏协会 Circulation. 2019 Nov 12;140(20):e774-e801.

2019年11月,美国心脏协会(AHA)发布了急性肺栓塞介入治疗—当前状况和新证据发展声明。肺栓塞(PE)是导致心血管疾病死亡的第三大原因,急性中高危PE的管理技术正在发生迅速变化。本文的主要目的是阐明急性PE介入治疗现状,并未新设备的开发提供证据。

中文标题:

2019 AHA科学声明:急性肺栓塞介入治疗—当前状况和新证据发展

英文标题:

Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association.

发布机构:

美国心脏协会

发布日期:

2019-11-04

简要介绍:

2019年11月,美国心脏协会(AHA)发布了急性肺栓塞介入治疗—当前状况和新证据发展声明。肺栓塞(PE)是导致心血管疾病死亡的第三大原因,急性中高危PE的管理技术正在发生迅速变化。本文的主要目的是阐明急性PE介入治疗现状,并未新设备的开发提供证据。

 

拓展指南:肺栓塞相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 AHA科学声明:急性肺栓塞介入治疗—当前状况和新证据发展)] GetToolGuiderByIdResponse(projectId=1, id=782fb1c001829e4d, title=2019 AHA科学声明:急性肺栓塞介入治疗—当前状况和新证据发展, enTitle=Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association., guiderFrom=Circulation. 2019 Nov 12;140(20):e774-e801., authorId=null, author=, summary=2019年11月,美国心脏协会(AHA)发布了急性肺栓塞介入治疗—当前状况和新证据发展声明。肺栓塞(PE)是导致心血管疾病死亡的第三大原因,急性中高危PE的管理技术正在发生迅速变化。本文的主要目的是阐明急性PE介入治疗现状,并未新设备的开发提供证据。 , cover=, journalId=null, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会(AHA,American Heart Association)是心脏病学领域比较正要的学会之一,致力于心脏病和卒中的预防与治疗,提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等,有官方杂志《美国心脏协会杂志》,提供心血管疾病和卒中相关的指南及专家共识,更新的比较快。, copyright=0, guiderPublishedTime=Mon Nov 04 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年11月,美国心脏协会(AHA)发布了急性肺栓塞介入治疗—当前状况和新证据发展声明。肺栓塞(PE)是导致心血管疾病死亡的第三大原因,急性中高危PE的管理技术正在发生迅速变化。本文的主要目的是阐明急性PE介入治疗现状,并未新设备的开发提供证据。 </P> <P> </P>拓展指南:<strong>与<font color=red>肺栓塞</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=60b8d1c00180e1c9" title="《2019年欧洲心脏病学会急性肺栓塞诊断和管理指南》要点更新及解读" target=_blank>《2019年欧洲心脏病学会急性肺栓塞诊断和管理指南》要点更新及解读</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=e14c31c001603eb5" title="2018 BTS指南:肺栓塞早期门诊管理" target=_blank>2018 BTS指南:肺栓塞早期门诊管理</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=27a281c00151e10f" title="妇科手术后深静脉血栓形成及肺栓塞预防专家共识" target=_blank>妇科手术后深静脉血栓形成及肺栓塞预防专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=0285f1c001353605" title="急性肺栓塞的危险分层及诊断策略—解读《2008ESC急性肺栓塞诊断治疗指南》" target=_blank>急性肺栓塞的危险分层及诊断策略—解读《2008ESC急性肺栓塞诊断治疗指南》</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=c30491c0013a0ea4" title="2015 NICE技术评估指南:阿哌沙班用于深静脉血栓形成和/或肺栓塞的治疗和二级预防(TA341)" target=_blank>2015 NICE技术评估指南:阿哌沙班用于深静脉血栓形成和/或肺栓塞的治疗和二级预防(TA341)</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E8%82%BA%E6%A0%93%E5%A1%9E" target=_blank>有关肺栓塞更多指南</a></ul>, tagList=[TagDto(tagId=17921, tagName=急性肺栓塞), TagDto(tagId=445, tagName=介入治疗)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6999, appHits=573, showAppHits=6, pcHits=2589, showPcHits=5053, likes=101, shares=9, comments=8, approvalStatus=1, publishedTime=Tue Nov 19 23:03:02 CST 2019, publishedTimeString=2019-11-04, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Nov 19 23:03:02 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:26:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 AHA科学声明:急性肺栓塞介入治疗—当前状况和新证据发展)])
2019 AHA科学声明:急性肺栓塞介入治疗—当前状况和新证据发展
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1066631, encodeId=805b106663151, content=积分积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8625648556, createdName=ms6000001197628119, createdTime=Wed Nov 03 16:40:51 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977143, encodeId=fc7d9e71439a, content=来求积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=oywRKRLSzibJMv3JHUmUVJQ&s=100&t=1557394800, createdBy=81e05325887, createdName=任我行3313, createdTime=Sat Jun 26 22:11:00 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974970, encodeId=a6689e49706b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ba5447974, createdName=ms7000001124466419, createdTime=Sat Jun 19 20:03:19 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946853, encodeId=c67994685354, content=积分积分!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210309/f528da7d20e643d48d3312f0c73c7146/be33382cfe0c4e8d89a2ba487b5576b6.jpg, createdBy=0f0b5467277, createdName=ms6000001183112020, createdTime=Tue Mar 09 17:27:10 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897691, encodeId=035c89e69199, content=下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5274771778, createdName=church12345, createdTime=Sun Nov 08 10:50:46 CST 2020, time=2020-11-08, status=1, ipAttribution=)]
    2021-11-03 ms6000001197628119

    积分积分了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1066631, encodeId=805b106663151, content=积分积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8625648556, createdName=ms6000001197628119, createdTime=Wed Nov 03 16:40:51 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977143, encodeId=fc7d9e71439a, content=来求积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=oywRKRLSzibJMv3JHUmUVJQ&s=100&t=1557394800, createdBy=81e05325887, createdName=任我行3313, createdTime=Sat Jun 26 22:11:00 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974970, encodeId=a6689e49706b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ba5447974, createdName=ms7000001124466419, createdTime=Sat Jun 19 20:03:19 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946853, encodeId=c67994685354, content=积分积分!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210309/f528da7d20e643d48d3312f0c73c7146/be33382cfe0c4e8d89a2ba487b5576b6.jpg, createdBy=0f0b5467277, createdName=ms6000001183112020, createdTime=Tue Mar 09 17:27:10 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897691, encodeId=035c89e69199, content=下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5274771778, createdName=church12345, createdTime=Sun Nov 08 10:50:46 CST 2020, time=2020-11-08, status=1, ipAttribution=)]
    2021-06-26 任我行3313

    来求积分

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1066631, encodeId=805b106663151, content=积分积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8625648556, createdName=ms6000001197628119, createdTime=Wed Nov 03 16:40:51 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977143, encodeId=fc7d9e71439a, content=来求积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=oywRKRLSzibJMv3JHUmUVJQ&s=100&t=1557394800, createdBy=81e05325887, createdName=任我行3313, createdTime=Sat Jun 26 22:11:00 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974970, encodeId=a6689e49706b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ba5447974, createdName=ms7000001124466419, createdTime=Sat Jun 19 20:03:19 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946853, encodeId=c67994685354, content=积分积分!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210309/f528da7d20e643d48d3312f0c73c7146/be33382cfe0c4e8d89a2ba487b5576b6.jpg, createdBy=0f0b5467277, createdName=ms6000001183112020, createdTime=Tue Mar 09 17:27:10 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897691, encodeId=035c89e69199, content=下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5274771778, createdName=church12345, createdTime=Sun Nov 08 10:50:46 CST 2020, time=2020-11-08, status=1, ipAttribution=)]
    2021-06-19 ms7000001124466419

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1066631, encodeId=805b106663151, content=积分积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8625648556, createdName=ms6000001197628119, createdTime=Wed Nov 03 16:40:51 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977143, encodeId=fc7d9e71439a, content=来求积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=oywRKRLSzibJMv3JHUmUVJQ&s=100&t=1557394800, createdBy=81e05325887, createdName=任我行3313, createdTime=Sat Jun 26 22:11:00 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974970, encodeId=a6689e49706b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ba5447974, createdName=ms7000001124466419, createdTime=Sat Jun 19 20:03:19 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946853, encodeId=c67994685354, content=积分积分!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210309/f528da7d20e643d48d3312f0c73c7146/be33382cfe0c4e8d89a2ba487b5576b6.jpg, createdBy=0f0b5467277, createdName=ms6000001183112020, createdTime=Tue Mar 09 17:27:10 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897691, encodeId=035c89e69199, content=下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5274771778, createdName=church12345, createdTime=Sun Nov 08 10:50:46 CST 2020, time=2020-11-08, status=1, ipAttribution=)]
    2021-03-09 ms6000001183112020

    积分积分!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1066631, encodeId=805b106663151, content=积分积分了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8625648556, createdName=ms6000001197628119, createdTime=Wed Nov 03 16:40:51 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977143, encodeId=fc7d9e71439a, content=来求积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=oywRKRLSzibJMv3JHUmUVJQ&s=100&t=1557394800, createdBy=81e05325887, createdName=任我行3313, createdTime=Sat Jun 26 22:11:00 CST 2021, time=2021-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974970, encodeId=a6689e49706b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ba5447974, createdName=ms7000001124466419, createdTime=Sat Jun 19 20:03:19 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946853, encodeId=c67994685354, content=积分积分!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210309/f528da7d20e643d48d3312f0c73c7146/be33382cfe0c4e8d89a2ba487b5576b6.jpg, createdBy=0f0b5467277, createdName=ms6000001183112020, createdTime=Tue Mar 09 17:27:10 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897691, encodeId=035c89e69199, content=下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5274771778, createdName=church12345, createdTime=Sun Nov 08 10:50:46 CST 2020, time=2020-11-08, status=1, ipAttribution=)]
    2020-11-08 church12345

    下载

    0

Baidu
map
Baidu
map
Baidu
map